-
1 Comment
TAKE Solutions Limited is currently in a long term uptrend where the price is trading 19.9% above its 200 day moving average.
From a valuation standpoint, the stock is 83.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
TAKE Solutions Limited's total revenue sank by 66.8% to $2B since the same quarter in the previous year.
Its net income has dropped by 150.5% to $-255M since the same quarter in the previous year.
Finally, its free cash flow grew by 51.3% to $775M since the same quarter in the previous year.
Based on the above factors, TAKE Solutions Limited gets an overall score of 3/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
Sector | Healthcare |
Industry | Biotechnology |
ISIN | INE142I01023 |
PE Ratio | None |
---|---|
Beta | 0.57 |
Target Price | 275 |
Market Cap | 1B |
Dividend Yield | None |
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personalized medicine, wellness, and patient engagement; and medical device solution, such as technological transformation with chip level programming, wearables, DICOM devices, PROM, nano devices, and miOTs. TAKE Solutions Limited was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TAKE.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025